Evaluation of Atacand® (Candesartan) in Daily Medical Practice

CompletedOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

June 30, 2007

Conditions
Hypertension
Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00837720 - Evaluation of Atacand® (Candesartan) in Daily Medical Practice | Biotech Hunter | Biotech Hunter